Navidea Biopharmaceuticals Inc
OTC:NAVB

Watchlist Manager
Navidea Biopharmaceuticals Inc Logo
Navidea Biopharmaceuticals Inc
OTC:NAVB
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $10k

Wall Street
Price Targets

NAVB Price Targets Summary
Navidea Biopharmaceuticals Inc

There are no price targets for NAVB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Navidea Biopharmaceuticals Inc Competitors:
Price Targets
EBMT
Eagle Bancorp Montana Inc
-15% Downside
WINA
Winmark Corp
22% Upside
ONDS
Ondas Holdings Inc
-1% Downside
VERK
Verkkokauppa.com Oyj
22% Upside
PWP
Perella Weinberg Partners
6% Upside

Revenue
Forecast

-43% / Year
Past Growth
261% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
-43% / Year
Past Growth
261% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

For the last 8 years the compound annual growth rate for Navidea Biopharmaceuticals Inc's revenue is -43%. The projected CAGR for the next 2 years is 261%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-77%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-77%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NAVB's stock price target?
Not Available

NAVB doesn't have any price targets made by Wall Street professionals.

What is Navidea Biopharmaceuticals Inc's Revenue forecast?
Projected CAGR
261%

For the last 8 years the compound annual growth rate for Navidea Biopharmaceuticals Inc's revenue is -43%. The projected CAGR for the next 2 years is 261%.

Back to Top